Nanjing Chia-Tai Tianqing Pharmaceutical Company to Speak at ACCESS CHINA Partnering Forum

January 3rd, 2025 (Shanghai) — We are glad to announce that Liu Ying, Business Development Manager of Nanjing Chia-Tai Tianqing Pharmaceutical Company, will be presenting at the ACCESS CHINA Partnering Forum @ JPM on January 7th-9th, and 21st-23rd, 2025. ACCESS CHINA Biotech Forum is the largest corporate access event between Asia and the Western biopharma industry.

About Nanjing Chia-Tai Tianqing Pharmaceutical Company

Nanjing Chia-Tai Tianqing Pharmaceutical Company, or NJCTTQ for short, was founded in August 2001 with its headquarters in the Nanjing Economic and Technological Development Zone. NJCTTQ integrates drug R&D, manufacturing, and commercialization. It is one of over 20 subsidiaries of Sino Biopharm, a HKEX-listed company (HKEX: 01177). In 2023, the company’s sales revenue exceeded 5.2 billion Chinese yuan. At present, NJCTTQ has two wholly-owned subsidiaries: Nanjing Chia-Tai Vican (which specializes in marketing and distributing medical products) and Jiangsu Pure Biomedical (which is an API plant). Knowing innovation is the lifeblood for any pharmaceutical company to pursue sustainable development, NJCTTQ, since a few years ago, has accelerated in-house R&D of novel drugs, many of which are now at different clinical stages, covering areas of oncology, hematology, nephrology, and metabolic disorders, etc.

About the speaker

Liu Ying, BD Manager from Nanjing Chia-Tai Tianqing Pharmaceutical Company, has almost 8 years of experience working in the pharmaceutical industry, currently responsible for BD activities outside China.

About ACCESS CHINA Partnering Forum

ACCESS CHINA Partnering Forum @ JPM is scheduled to be held on January 7th-9th, and 21st-23rd, 2025, via Zoom webinar. This event helps biotechs/pharmas efficiently present their assets in front of 500+ healthcare companies and VCs online. During the event, the audience can have access to innovative pharma and healthcare products from worldwide.

Conference Name: ACCESS CHINA Partnering Forum

Date & Time: January 7-9 (Live), and 21-23(VoD), 2025, China time

Content: Keynote Speeches, Panel Discussion, Company Presentations, ChemPartner-ACCESS CHINA Dinner Reception

Scale: Expected 500+ participants Online; 100 company roadshows

Participants: Pharma/Biotech senior management and BDs

View more information at https://biotochina.org/